Cryptogenic Stroke and Underlying Atrial Fibrillation
Tommaso Sanna(Università Cattolica del Sacro Cuore), Johannes Brachmann(Klinikum Coburg), Marilyn M. Rymer(Cleveland Clinic), Kate Lindborg(Medtronic (United States)), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Vincenzo Di Lazzaro(Università Campus Bio-Medico), Carlos A. Morillo(Spanish National Centre for Cardiovascular Research), Richard A. Bernstein(Northwestern University), Hans‐Christoph Diener(Vivantes Klinikum), Frank Beckers(Medtronic (Netherlands)), Tyson Rogers(Medtronic (United States)), Rod Passman(Northwestern University)
Cited by 2,155
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
|Clinical Neurophysiology|2014|2.2k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k
Part 8: Adult Advanced Cardiovascular Life Support
|Circulation|2010|1.6k